FindTrial
Sign In

The Comparison and Analysis of Sedation Drugs in Intracerebral Hemorrhage: Dexmedetomidine vs. Propofol, Comparison of Days in Intensive Care Unit and Duration of Mechanical Ventilation

The Comparison and Analysis of Sedation Drugs in Intracerebral Hemorrhage: Dexmedetomidine vs. Propofol, Comparison of Days in Intensive Care Unit and Duration of Mechanical Ventilation

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004428
Enrollment
300
Registered
2019-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1) Dexmedetomidine dosage: 0.1-0.6 mcg/kg/hr number of administration: continuous duration: while patient is admitted in the ICU administration site: via peripheral intravenous line 2) Propofo

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Brain hemorrhage (intracerebral hemorrhage, intraventricular hemorrhage, subdural hematoma, epidural hematoma) patient who is admitted to intensive care unit

Exclusion criteria

Exclusion criteria: Patient who is less than 18 years old or greater than 80 years old, patient who is currently taking antiplatelet or anticoagulation agents, terminal cancer patients, diagnosis of medical disease (such as pneumonia, sepsis, disseminated intravascular coagulation, shock) during intensive care unit admission

Design outcomes

Secondary

MeasureTime frame
Duration of intubation period—

Primary

MeasureTime frame
Duration of intensive care unit stay—

Countries

Korea, Republic of

Contacts

Public ContactMoinay Kim

University of Ulsan

aussie84@naver.com+82-2-3010-3550

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026